Jerome B. Zeldis, Director at Alliqua BioMedical, Inc. (ALQA), bought 14,000 shares at $2.91 ($41K) on 2015-11-06, disclosed to the SEC on 2015-11-09.
Open-market purchase of $41k ALQA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| NXGL | BUY | 2024-08-27 | $25K | — | Filing → |
| PTCT | SELL | 2024-05-24 | $765K | — | Filing → |
| NXGL | BUY | 2023-05-30 | $12K | — | Filing → |